Working to Eradicate Gynecologic Cancers

Clinical considerations and toxicities with PI3K pathway and MEK inhibitors

Sunday, March 29, 2015: 7:10 AM
Grand Ballroom (Hilton Chicago)
J. F. Liu
Dana-Farber Cancer Institute, Boston, MA
 
 
See more of: Sunrise Seminar III: Avoiding Clinical Catastrophes when Incorporating Novel Targeted Agents into Care of Gynecologic Cancer Patients
See more of: Sunrise Seminar
<< Previous Presentation | Next Presentation >>